Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Avid licenses protease inhibitor from DuPont Merck

Jan. 14, 1997

Viracept expanded access program broadened

Jan. 13, 1997

Gene therapy for AIDS to enter clinical testing in U.S.

Jan. 13, 1997

Further U.S. patent on Celtrix's SomatoKine

Jan. 10, 1997

Panretin phase I/II data described

Jan. 10, 1997

Viracept now available to children

Jan. 9, 1997

Protease inhibitor review published

Jan. 9, 1997

Study results reported for Genentech AIDS vaccine candidate

Jan. 9, 1997

Potential HIV-1 therapy disclosed by Houghten

Jan. 9, 1997

Comparative clinical trials with Viracept

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...